Skip to content
Screener

Thermo Fisher Scientific TMO Analytical Instruments — Operating Income (Loss)

Other segment segments

Life Sciences Solutions
$1.04B+13.2%
Laboratory Products and Biopharma Services
$936M+13.3%
Specialty Diagnostics
$334M+8.8%

Similar metrics at other companies

Flotek Industries logo
FTKData Analytics — Operating Income (Loss)
$10.16M+630%
NAG
NAGEAnalytical Reference Standards and Services segment — Operating Income (Loss)
$71K+14.5%
Public Storage logo
PSAAncillary operations — Operating Income (Loss)
$56.65M+15.3%
NiSource logo
NINIPSCO Operations — Operating Income (Loss)
$120.4M-10.1%
Tejon Ranch logo
TRCRanch operations — Operating Income (Loss)
-$93K+63.1%
CSX logo
CSXRail Operations — Operating Income (Loss)
$1.49B+16.9%

Other financials

Income statement

See full
Revenue$12.0B
Operating income$2.1B
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$213.65B+26.0%
Enterprise value$248.77B+22.9%
P/E30.7×+4.9×
P/S4.8×-0.9×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Thermo Fisher Scientific’s 8-K, filed July 23, 2026. Open the filing →

Filed
Jul 23, 2026, 6:04 AM EDT
Accession
0000097745-26-000138

FAQ

What is Thermo Fisher Scientific's analytical instruments — operating income (loss)?
Thermo Fisher Scientific (TMO) reported analytical instruments — operating income (loss) of $424M in Q2 2026.
How has Thermo Fisher Scientific's analytical instruments — operating income (loss) changed year-over-year?
Thermo Fisher Scientific's analytical instruments — operating income (loss) increased by 30.5% year-over-year, from $325M to $424M.
What is the long-term trend for Thermo Fisher Scientific's analytical instruments — operating income (loss)?
Over 4 years (2021 to 2025), Thermo Fisher Scientific's analytical instruments — operating income (loss) has grown at a 9.7% compound annual growth rate (CAGR), from $1.2B to $1.74B.
What does analytical instruments — operating income (loss) mean?
The profit or loss generated by the Analytical Instruments segment after deducting all operating expenses from total revenues. It measures the core operational profitability of the segment before interest, taxes, and corporate-level allocations.

Ask your AI about Thermo Fisher Scientific's analytical instruments — operating income (loss).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude